Comparison of Levofloxacin, Alatrofloxacin, and Vancomycin for Prophylaxis and Treatment of Experimental Foreign-Body-Associated Infection by Methicillin-Resistant Staphylococcus aureus
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...
Gespeichert in:
| Veröffentlicht in: | Antimicrobial Agents and Chemotherapy 2002-05, Vol.46 (5), p.1503-1509 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1509 |
|---|---|
| container_issue | 5 |
| container_start_page | 1503 |
| container_title | Antimicrobial Agents and Chemotherapy |
| container_volume | 46 |
| creator | VAUDAUX, Pierre FRANCOIS, Patrice BISOGNANO, Carmelo SCHRENZEL, Jacques LEW, Daniel P |
| description | Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
|
| doi_str_mv | 10.1128/AAC.46.5.1503-1509.2002 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_11959588</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18453412</sourcerecordid><originalsourceid>FETCH-LOGICAL-a544t-88327426b88e84d0b152f0ae2d517fc1e708d0d61a219a1911a2f3790e6bdbca3</originalsourceid><addsrcrecordid>eNqNUsGO0zAUjBCILQu_AOEAJ1Jsx07swx5KtQsrFYFg4Wq9OE7rlWMXO1naT-PvcGhFlxsX26M388bP4yx7gdEcY8LfLhbLOa3mbI4ZKou0iDlBiDzIZhgJXlRMVA-zGUJVVVCO6Fn2JMZblDAT6HF2hrFggnE-y34tfb-FYKJ3ue_ylb7znfU7UMa9yRcWhnAPg2vz7-CU7_cJ550P-efgt5u9hZ2Jf8o3QcPQazdM3S53Wx3MhMDmVz5os3bFO9_ui0WMXhkYdJtfu06rwST_Zp9_1MPGKGOtccUXHU0cILX6OsBk4pVXakw-Y9BjfJo96sBG_ey4n2ffri5vlh-K1af318vFqgBG6VBwXpKakqrhXHPaogYz0iHQpGW47hTWNeItaisMBAvAAqdDV9YC6appGwXleXZx6Lsdm163Kk0TwMptGgzCXnow8t-KMxu59ncSkxozlvSvj_rgf4w6DrI3UWlrwWk_Rok5ZSXFJBHrA1EFH2PQ3V8PjOSUukypS1pJJqfUp0XIKfWkpAclxJ7IWz8Gl17kP2TP7092sjv-jkR4dSRAVGC7kLI38cQrKyIwmUZ8eeBtzHrz0wQt00UkgDrZlr8B9BTWZQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18453412</pqid></control><display><type>article</type><title>Comparison of Levofloxacin, Alatrofloxacin, and Vancomycin for Prophylaxis and Treatment of Experimental Foreign-Body-Associated Infection by Methicillin-Resistant Staphylococcus aureus</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>VAUDAUX, Pierre ; FRANCOIS, Patrice ; BISOGNANO, Carmelo ; SCHRENZEL, Jacques ; LEW, Daniel P</creator><creatorcontrib>VAUDAUX, Pierre ; FRANCOIS, Patrice ; BISOGNANO, Carmelo ; SCHRENZEL, Jacques ; LEW, Daniel P</creatorcontrib><description>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.46.5.1503-1509.2002</identifier><identifier>PMID: 11959588</identifier><identifier>CODEN: AACHAX</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Animals ; Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Anti-Infective Agents ; Anti-Infective Agents - pharmacokinetics ; Anti-Infective Agents - pharmacology ; Anti-Infective Agents - therapeutic use ; Antibacterial agents ; Antibiotic Prophylaxis ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Biological and medical sciences ; Disease Models, Animal ; Experimental Therapeutics ; Fluoroquinolones ; Foreign-Body Reaction ; Foreign-Body Reaction - drug therapy ; Foreign-Body Reaction - prevention & control ; Guinea Pigs ; Humans ; Levofloxacin ; Medical sciences ; Methicillin Resistance ; Microbial Sensitivity Tests ; Ofloxacin ; Ofloxacin - pharmacokinetics ; Ofloxacin - pharmacology ; Ofloxacin - therapeutic use ; Pharmacology. Drug treatments ; Rats ; Staphylococcal Infections - drug therapy ; Staphylococcal Infections - prevention & control ; Staphylococcus aureus ; Staphylococcus aureus - drug effects ; Vancomycin - pharmacology ; Vancomycin - therapeutic use</subject><ispartof>Antimicrobial Agents and Chemotherapy, 2002-05, Vol.46 (5), p.1503-1509</ispartof><rights>2002 INIST-CNRS</rights><rights>Copyright © 2002 American Society for Microbiology</rights><rights>Copyright © 2002, American Society for Microbiology 2002</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a544t-88327426b88e84d0b152f0ae2d517fc1e708d0d61a219a1911a2f3790e6bdbca3</citedby><cites>FETCH-LOGICAL-a544t-88327426b88e84d0b152f0ae2d517fc1e708d0d61a219a1911a2f3790e6bdbca3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC127155/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC127155/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13629125$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11959588$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>VAUDAUX, Pierre</creatorcontrib><creatorcontrib>FRANCOIS, Patrice</creatorcontrib><creatorcontrib>BISOGNANO, Carmelo</creatorcontrib><creatorcontrib>SCHRENZEL, Jacques</creatorcontrib><creatorcontrib>LEW, Daniel P</creatorcontrib><title>Comparison of Levofloxacin, Alatrofloxacin, and Vancomycin for Prophylaxis and Treatment of Experimental Foreign-Body-Associated Infection by Methicillin-Resistant Staphylococcus aureus</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>AAC</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><subject>Animals</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Anti-Infective Agents</subject><subject>Anti-Infective Agents - pharmacokinetics</subject><subject>Anti-Infective Agents - pharmacology</subject><subject>Anti-Infective Agents - therapeutic use</subject><subject>Antibacterial agents</subject><subject>Antibiotic Prophylaxis</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Biological and medical sciences</subject><subject>Disease Models, Animal</subject><subject>Experimental Therapeutics</subject><subject>Fluoroquinolones</subject><subject>Foreign-Body Reaction</subject><subject>Foreign-Body Reaction - drug therapy</subject><subject>Foreign-Body Reaction - prevention & control</subject><subject>Guinea Pigs</subject><subject>Humans</subject><subject>Levofloxacin</subject><subject>Medical sciences</subject><subject>Methicillin Resistance</subject><subject>Microbial Sensitivity Tests</subject><subject>Ofloxacin</subject><subject>Ofloxacin - pharmacokinetics</subject><subject>Ofloxacin - pharmacology</subject><subject>Ofloxacin - therapeutic use</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Staphylococcal Infections - drug therapy</subject><subject>Staphylococcal Infections - prevention & control</subject><subject>Staphylococcus aureus</subject><subject>Staphylococcus aureus - drug effects</subject><subject>Vancomycin - pharmacology</subject><subject>Vancomycin - therapeutic use</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNUsGO0zAUjBCILQu_AOEAJ1Jsx07swx5KtQsrFYFg4Wq9OE7rlWMXO1naT-PvcGhFlxsX26M388bP4yx7gdEcY8LfLhbLOa3mbI4ZKou0iDlBiDzIZhgJXlRMVA-zGUJVVVCO6Fn2JMZblDAT6HF2hrFggnE-y34tfb-FYKJ3ue_ylb7znfU7UMa9yRcWhnAPg2vz7-CU7_cJ550P-efgt5u9hZ2Jf8o3QcPQazdM3S53Wx3MhMDmVz5os3bFO9_ui0WMXhkYdJtfu06rwST_Zp9_1MPGKGOtccUXHU0cILX6OsBk4pVXakw-Y9BjfJo96sBG_ey4n2ffri5vlh-K1af318vFqgBG6VBwXpKakqrhXHPaogYz0iHQpGW47hTWNeItaisMBAvAAqdDV9YC6appGwXleXZx6Lsdm163Kk0TwMptGgzCXnow8t-KMxu59ncSkxozlvSvj_rgf4w6DrI3UWlrwWk_Rok5ZSXFJBHrA1EFH2PQ3V8PjOSUukypS1pJJqfUp0XIKfWkpAclxJ7IWz8Gl17kP2TP7092sjv-jkR4dSRAVGC7kLI38cQrKyIwmUZ8eeBtzHrz0wQt00UkgDrZlr8B9BTWZQ</recordid><startdate>20020501</startdate><enddate>20020501</enddate><creator>VAUDAUX, Pierre</creator><creator>FRANCOIS, Patrice</creator><creator>BISOGNANO, Carmelo</creator><creator>SCHRENZEL, Jacques</creator><creator>LEW, Daniel P</creator><general>American Society for Microbiology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>5PM</scope></search><sort><creationdate>20020501</creationdate><title>Comparison of Levofloxacin, Alatrofloxacin, and Vancomycin for Prophylaxis and Treatment of Experimental Foreign-Body-Associated Infection by Methicillin-Resistant Staphylococcus aureus</title><author>VAUDAUX, Pierre ; FRANCOIS, Patrice ; BISOGNANO, Carmelo ; SCHRENZEL, Jacques ; LEW, Daniel P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a544t-88327426b88e84d0b152f0ae2d517fc1e708d0d61a219a1911a2f3790e6bdbca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Animals</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Anti-Infective Agents</topic><topic>Anti-Infective Agents - pharmacokinetics</topic><topic>Anti-Infective Agents - pharmacology</topic><topic>Anti-Infective Agents - therapeutic use</topic><topic>Antibacterial agents</topic><topic>Antibiotic Prophylaxis</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Biological and medical sciences</topic><topic>Disease Models, Animal</topic><topic>Experimental Therapeutics</topic><topic>Fluoroquinolones</topic><topic>Foreign-Body Reaction</topic><topic>Foreign-Body Reaction - drug therapy</topic><topic>Foreign-Body Reaction - prevention & control</topic><topic>Guinea Pigs</topic><topic>Humans</topic><topic>Levofloxacin</topic><topic>Medical sciences</topic><topic>Methicillin Resistance</topic><topic>Microbial Sensitivity Tests</topic><topic>Ofloxacin</topic><topic>Ofloxacin - pharmacokinetics</topic><topic>Ofloxacin - pharmacology</topic><topic>Ofloxacin - therapeutic use</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Staphylococcal Infections - drug therapy</topic><topic>Staphylococcal Infections - prevention & control</topic><topic>Staphylococcus aureus</topic><topic>Staphylococcus aureus - drug effects</topic><topic>Vancomycin - pharmacology</topic><topic>Vancomycin - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>VAUDAUX, Pierre</creatorcontrib><creatorcontrib>FRANCOIS, Patrice</creatorcontrib><creatorcontrib>BISOGNANO, Carmelo</creatorcontrib><creatorcontrib>SCHRENZEL, Jacques</creatorcontrib><creatorcontrib>LEW, Daniel P</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>VAUDAUX, Pierre</au><au>FRANCOIS, Patrice</au><au>BISOGNANO, Carmelo</au><au>SCHRENZEL, Jacques</au><au>LEW, Daniel P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of Levofloxacin, Alatrofloxacin, and Vancomycin for Prophylaxis and Treatment of Experimental Foreign-Body-Associated Infection by Methicillin-Resistant Staphylococcus aureus</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><stitle>AAC</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2002-05-01</date><risdate>2002</risdate><volume>46</volume><issue>5</issue><spage>1503</spage><epage>1509</epage><pages>1503-1509</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><coden>AACHAX</coden><abstract>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>11959588</pmid><doi>10.1128/AAC.46.5.1503-1509.2002</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0066-4804 |
| ispartof | Antimicrobial Agents and Chemotherapy, 2002-05, Vol.46 (5), p.1503-1509 |
| issn | 0066-4804 1098-6596 |
| language | eng |
| recordid | cdi_pubmed_primary_11959588 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
| subjects | Animals Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Anti-Infective Agents Anti-Infective Agents - pharmacokinetics Anti-Infective Agents - pharmacology Anti-Infective Agents - therapeutic use Antibacterial agents Antibiotic Prophylaxis Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Disease Models, Animal Experimental Therapeutics Fluoroquinolones Foreign-Body Reaction Foreign-Body Reaction - drug therapy Foreign-Body Reaction - prevention & control Guinea Pigs Humans Levofloxacin Medical sciences Methicillin Resistance Microbial Sensitivity Tests Ofloxacin Ofloxacin - pharmacokinetics Ofloxacin - pharmacology Ofloxacin - therapeutic use Pharmacology. Drug treatments Rats Staphylococcal Infections - drug therapy Staphylococcal Infections - prevention & control Staphylococcus aureus Staphylococcus aureus - drug effects Vancomycin - pharmacology Vancomycin - therapeutic use |
| title | Comparison of Levofloxacin, Alatrofloxacin, and Vancomycin for Prophylaxis and Treatment of Experimental Foreign-Body-Associated Infection by Methicillin-Resistant Staphylococcus aureus |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T18%3A49%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20Levofloxacin,%20Alatrofloxacin,%20and%20Vancomycin%20for%20Prophylaxis%20and%20Treatment%20of%20Experimental%20Foreign-Body-Associated%20Infection%20by%20Methicillin-Resistant%20Staphylococcus%20aureus&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=VAUDAUX,%20Pierre&rft.date=2002-05-01&rft.volume=46&rft.issue=5&rft.spage=1503&rft.epage=1509&rft.pages=1503-1509&rft.issn=0066-4804&rft.eissn=1098-6596&rft.coden=AACHAX&rft_id=info:doi/10.1128/AAC.46.5.1503-1509.2002&rft_dat=%3Cproquest_pubme%3E18453412%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18453412&rft_id=info:pmid/11959588&rfr_iscdi=true |